December 4, 2017 /

Capricor Therapeutics’ HOPE-Duchenne Clinical Trial (November 2017)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Capricor Therapeutics’ HOPE-Duchenne Clinical Trial (November 2017)

Capricor Therapeutics joined PPMD for a webinar on November 30, 2017 to discuss the 12-month results from Capricor’s HOPE-Duchenne Clinical Trial, as well as the company’s plans for the HOPE-2 Clinical Trial in the first quarter of 2018, pending regulatory approval.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo